ArticlePsychogeriatrics : the official journal of the Japanese Psychogeriatric Society2026
Improvement in Delusional Jealousy and Caregiver Distress After Switching From Oral Galantamine to a Donepezil Transdermal Patch in Alzheimer's Disease: A Case Report.
Article in Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) are common and strongly associated with caregiver distress. Switching cholinesterase inhibitors (ChEIs) may be considered when NPS remain clinically problematic. Although switching ChEIs may improve NPS in some patients, published reports describing improvement in delusional jealousy after switching to a donepezil transdermal patch remain limited. CASE PRESENTATION: We report a woman in her 60s with probable AD who developed caregiver-reported delusional jealousy and near-daily marital conflicts during oral galantamine therapy. NPS were assessed using the caregiver-rated Neuropsychiatric Inventory Questionnaire (NPI-Q) at three time points: prior to initiating galantamine (baseline symptoms were predominantly non-psychotic), immediately prior to switching and 6 months after switching. Total NPI-Q severity increased from 4 to 20 and then decreased to 11; total caregiver distress increased from 3 to 31 and then decreased to 13. After switching from oral galantamine, 16 mg/day, to a donepezil transdermal patch, 27.5 mg/day, improvements in domain-level severity were observed in the delusions domain, driven mainly by reduced caregiver-rated delusional jealousy, as well as in agitation/aggression, disinhibition and irritability/lability. Clinically, the conviction of delusional jealousy gradually diminished with a reduction in conflict frequency; at 6 months, delusional jealousy had almost completely resolved, whereas caregiver-attributed negative self-appraisals (e.g., a persistent belief that she was useless, perceived by the caregiver as delusional) persisted. No psychotropic medications were initiated or dose-adjusted from immediately prior to switching through the 6-month follow-up. Subsequently, the patient became able to attend day care services.
conclusionThis case suggests that switching from oral galantamine to a donepezil transdermal patch may be associated with improvement in delusional jealousy, selected caregiver-rated NPS domains and caregiver distress in some patients, although causal inference is not possible in a single case and responses may vary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.